SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NRIX

Nurix Therapeutics Inc.
NASDAQHealth Care

Latest close: 24.42 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Reported sale · Form 4Gwenn Hansen, Chief Scientific Officer · $36.3KOpen the filing ↗
  2. Oct 14, 2026Reported sale · Form 4JULIA P GREGORY · $528.5KOpen the filing ↗
  3. Oct 14, 2026Notice of sale · Form 144JULIA GREGORY · Director · $528.5KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record52219 flagged findings
Reported transactions (Form 4)80since Feb 10, 2026 · and 1 other holding
Corporate events (8-K)18since Oct 26, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-08share offering or dilution eventrecentOpen filing ↗
    “…Company’s common stock at a price of $ 13.939 per pre-funded warrant. As of February 28, 2026, a total of 6,097,560 of the 2022…”
    +1 more passage from the same document
    • “…stock, at a public offering price of $15.00 per share, and (b) pre-funded warrants to purchase 1,500,100 shares of our common stock…”
  • 2026-04-08export control restrictionsrecentOpen filing ↗
    “…for such purposes. For any activities conducted in China, we are exposed to the possibility of product supply disruption and…”
    +1 more passage from the same document
    • “…requirements to which our international operations might be subject or the manner in which existing laws might be administered or…”
  • 2026-04-08capital return (buybacks/dividends)recentOpen filing ↗
    “…or decrease this percentage not in excess of 19.99 % by providing at least 61 days’ prior notice to the Company. The pre-funded…”
    +1 more passage from the same document
    • “…tax year ending November 30, 2026. The enactment of OBBBA did not have a material impact on the condensed financial statements. 11.…”
  • 2026-04-08Department of Justice inquiryrecentOpen filing ↗
    “…effect on our operations and business and could adversely impact our stock price. 68 Table of Contents The FDA also may impose…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 522)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 26Form 4 ↗Insider transaction new
  • Oct 14, 26Form 144 ↗Notice of proposed sale new
  • Oct 14, 26Form 4 ↗Insider transaction new
  • Oct 13, 2610-Q ↗Quarterly report new
  • Oct 13, 268-K ↗Current report · Results new
  • Oct 2, 26Form 144 ↗Notice of proposed sale
  • Oct 2, 26Form 4 ↗Insider transaction
  • Sep 23, 26SCHEDULE 13G ↗Passive stake · Perceptive Advisors LLC · 5.3% · event on Sep 16, 26
  • Sep 2, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Deep Track Capital, LP · 7.5% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Redmile Group, LLC · 8.1% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Rubric Capital Management LP · 7.0% · event on Jun 30, 26
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Vestal Point Capital, LP · 7.8% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · T. Rowe Price Associates, Inc. · 5.3% · event on Jun 30, 26
  • Aug 5, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Aug 4, 26Form 4 ↗Insider transaction
  • Aug 3, 26Form 144 ↗Notice of proposed sale
  • Aug 3, 26Form 4 ↗Insider transaction
  • Jul 31, 26SCHEDULE 13G ↗Passive stake · Vanguard Capital Management · 5.0% · event on Jun 30, 26

522 filings on record, the oldest from Jun 4, 20.

Listing the 25 most recent filings of the 522 on record.

8-Ks, explained

Structure6Governance12
  • Jun 8, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2024 – 2025show all 4hide
    • Nov 10, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 22, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 13, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 16, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 12, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 7, 23StructureEntered a material agreement8-K 1.01 ↗
  • Apr 10, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 14, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 8, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 16, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 7, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 2, 22StructureEntered a material agreement8-K 1.01 ↗
  • Sep 30, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 9, 21StructureEntered a material agreement8-K 1.01 ↗

3 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Redmile Group, LLC8.1%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Vestal Point Capital, LP7.8%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Deep Track Capital, LP7.5%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Baker Bros. Advisors LP7.2%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Rubric Capital Management LP7.0%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
  • FMR LLC5.4%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Perceptive Advisors LLC5.3%Sep 16, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • T. Rowe Price Associates, Inc.5.3%Jun 30, 26SCHEDULE 13G ↗
  • Vanguard Capital Management5.0%Jun 30, 26SCHEDULE 13G ↗
  • Commodore Capital LP4.9%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 14, JULIA GREGORY filed notice of intent to sell up to $529K. That is about 0.02% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $529K on Oct 14, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 9 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 15, 26Sell$36KGwenn HansenChief Scientific Officer↗
  • Oct 14, 26Sell$529KJULIA P GREGORY↗
  • Oct 2, 26Sell$134KChristine RingChief Legal Officer↗
  • Sep 2, 26Sell$138KChristine RingChief Legal Officer↗
  • Sep 2, 26Sell$11KChristine RingChief Legal Officer↗
  • Sep 1, 26Sell$37KGwenn HansenChief Scientific Officer↗
  • Aug 5, 26Sell$109KGwenn HansenChief Scientific Officer↗
  • Aug 4, 26Sell$43KHoute Hans vanChief Financial Officer↗
  • Aug 4, 26Sell$73KHoute Hans vanChief Financial Officer↗
  • Aug 4, 26Sell$36KGwenn HansenChief Scientific Officer↗
  • Aug 4, 26Sell$64KGwenn HansenChief Scientific Officer↗
  • Aug 3, 26Sell$382KChristine RingChief Legal Officer↗

There are 7 more transactions in this stretch.

Stock compensation, tax and giftsshow the 21 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 15, 26Compensation$3KGwenn HansenChief Scientific Officer↗
  • Oct 14, 26Compensation$42KJULIA P GREGORY↗
  • Oct 2, 26Compensation$50KChristine RingChief Legal Officer↗
  • Sep 2, 26Compensation$50KChristine RingChief Legal Officer↗
  • Sep 1, 26Compensation$3KGwenn HansenChief Scientific Officer↗
  • Aug 5, 26Compensation$8KGwenn HansenChief Scientific Officer↗
  • Aug 3, 26Compensation$50KChristine RingChief Legal Officer↗
  • Jul 30, 26Compensationamount n/aGwenn HansenChief Scientific Officer↗
  • Jul 30, 26Compensationamount n/aGwenn HansenChief Scientific Officer↗
  • Jul 30, 26Compensationamount n/aGwenn HansenChief Scientific Officer↗
  • Jul 30, 26Compensationamount n/aChristine RingChief Legal Officer↗
  • Jul 30, 26Compensationamount n/aChristine RingChief Legal Officer↗
  • Jul 30, 26Compensationamount n/aChristine RingChief Legal Officer↗
  • Jul 30, 26Compensationamount n/aHoute Hans vanChief Financial Officer↗
  • Jul 30, 26Compensationamount n/aHoute Hans vanChief Financial Officer↗
  • Jul 30, 26Compensationamount n/aHoute Hans vanChief Financial Officer↗
  • Jul 2, 26Compensation$10KChristine RingChief Legal Officer↗
  • Jul 2, 26Compensation$50KChristine RingChief Legal Officer↗
  • Jun 25, 26Compensation$97KChristine RingChief Legal Officer↗
  • Jun 25, 26Compensation$136KChristine RingChief Legal Officer↗
  • Jun 2, 26Compensation$6KChristine RingChief Legal Officer↗

The full record holds 272 transactions and goes back to Jan 30, 23.

Its sector and its market

Nurix Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Nurix Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Nurix Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
522 documents on file, from Jun 4, 2020 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.